PACIRA BIOSCIENCES, INC. Increase (Decrease) in Restricted Cash
PACIRA BIOSCIENCES, INC. (PCRX) reported Increase (Decrease) in Restricted Cash of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2018-02-28
- PACIRA BIOSCIENCES, INC. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $0.00.
- PACIRA BIOSCIENCES, INC. increase (decrease) in restricted cash for the quarter ending 2016-09-30 was $0.00.
- PACIRA BIOSCIENCES, INC. increase (decrease) in restricted cash for the quarter ending 2016-06-30 was $0.00.
- PACIRA BIOSCIENCES, INC. increase (decrease) in restricted cash for the quarter ending 2016-03-31 was $0.00.
- PACIRA BIOSCIENCES, INC. increase (decrease) in restricted cash for fiscal 2017 was $0.00.
- PACIRA BIOSCIENCES, INC. increase (decrease) in restricted cash for fiscal 2016 was $0.00.
- PACIRA BIOSCIENCES, INC. increase (decrease) in restricted cash for fiscal 2015 was -$1.51M.
- PACIRA BIOSCIENCES, INC. increase (decrease) in restricted cash for fiscal 2014 was -$124.00K, a 212.73% decline from fiscal 2013.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 6 month as first filed | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-02-28 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 10-K · filed 2018-02-28 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $0.00 derived: sum of 2 quarters · filed 2016-11-02 | $0.00 10-Q · filed 2016-11-02 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $0.00 10-Q · filed 2016-08-04 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-02 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | -$1.51M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $0.00 derived: sum of 2 quarters · filed 2016-11-02 | -$1.51M 10-Q · filed 2016-11-02 | -$1.63M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$1.51M 10-Q · filed 2016-08-04 | -$1.63M derived: sum of 3 quarters · filed 2017-03-01 | -$1.97M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | -$1.51M 10-Q · filed 2016-05-02 | -$1.63M derived: sum of 2 quarters · filed 2017-03-01 | -$1.97M derived: sum of 3 quarters · filed 2017-03-01 | $196.00K derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | -$124.00K 10-K · filed 2017-03-01 | -$463.00K derived: sum of 2 quarters · filed 2017-03-01 | $1.71M derived: sum of 3 quarters · filed 2017-03-01 | -$124.00K 10-K · filed 2016-02-25 | |
| 2014-09-30 | -$339.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-27 | $1.83M derived: sum of 2 quarters · filed 2015-10-27 | $196.00K 10-Q · filed 2015-10-27 | -$146.00K derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $535.00K 10-Q · filed 2015-07-30 | $193.00K derived: sum of 3 quarters · filed 2016-02-25 | $1.17M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | -$1.63M 10-Q · filed 2015-04-30 | -$1.98M derived: sum of 2 quarters · filed 2016-02-25 | -$998.00K derived: sum of 3 quarters · filed 2016-02-25 | $0.00 derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | -$342.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $635.00K derived: sum of 2 quarters · filed 2016-02-25 | $1.63M derived: sum of 3 quarters · filed 2016-02-25 | $110.00K 10-K · filed 2016-02-25 | |
| 2013-09-30 | $977.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $1.98M derived: sum of 2 quarters · filed 2014-10-30 | $452.00K 10-Q · filed 2014-10-30 | $184.00K derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-06-30 | $998.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$525.00K 10-Q · filed 2014-07-31 | -$793.00K derived: sum of 3 quarters · filed 2015-02-24 | -$849.00K derived: sum of 4 quarters · filed 2015-02-24 | |
| 2013-03-31 | -$1.52M 10-Q · filed 2014-05-01 | -$1.79M derived: sum of 2 quarters · filed 2015-02-24 | -$1.85M derived: sum of 3 quarters · filed 2015-02-24 | $0.00 derived: sum of 4 quarters · filed 2015-02-24 | |
| 2012-12-31 | -$268.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$324.00K derived: sum of 2 quarters · filed 2015-02-24 | $1.52M derived: sum of 3 quarters · filed 2015-02-24 | $224.00K 10-K · filed 2015-02-24 | |
| 2012-09-30 | -$56.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $1.79M derived: sum of 2 quarters · filed 2013-10-31 | $492.00K 10-Q · filed 2013-10-31 | $105.00K derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-06-30 | $1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $548.00K 10-Q · filed 2013-08-06 | $161.00K derived: sum of 3 quarters · filed 2014-02-25 | -$221.00K derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-03-31 | -$1.30M 10-Q · filed 2013-05-08 | -$1.69M derived: sum of 2 quarters · filed 2014-02-25 | -$2.07M derived: sum of 3 quarters · filed 2014-02-25 | $1.00K derived: sum of 4 quarters · filed 2014-02-25 | |
| 2011-12-31 | -$387.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$769.00K derived: sum of 2 quarters · filed 2014-02-25 | $1.30M derived: sum of 3 quarters · filed 2014-02-25 | -$14.00K 10-K · filed 2014-02-25 | |
| 2011-09-30 | -$382.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $1.69M derived: sum of 2 quarters · filed 2012-11-01 | $373.00K 10-Q · filed 2012-11-01 | -$392.00K derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $755.00K 10-Q · filed 2012-08-09 | -$755.00K 10-Q · filed 2011-08-11 | -$10.00K derived: sum of 3 quarters · filed 2013-03-07 | $1.04M derived: sum of 4 quarters · filed 2013-03-07 |
| 2011-03-31 | -$1.31M 10-Q · filed 2012-05-09 | -$2.08M derived: sum of 2 quarters · filed 2013-03-07 | -$1.03M derived: sum of 3 quarters · filed 2013-03-07 | ||
| 2010-12-31 | -$765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $281.00K derived: sum of 2 quarters · filed 2013-03-07 | $98.00K 10-K · filed 2013-03-07 | ||
| 2010-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $863.00K 10-Q · filed 2011-10-31 | |||
| 2010-06-30 | -$183.00K 10-Q · filed 2011-08-11 | ||||
| 2009-12-31 | $34.00K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |